Stocks

Magazine articles on individual stocks, valuation, accounting standards, IPO's, brokerages, exchanges.

Old Articles: <Older 23031-23040 Newer>

The Motley Fool May 7, 2007 David Lee Smith	Clear Channel's Fuzzy Picture With an upcoming shareholder vote, a private-equity effort to acquire radio giant Clear Channel still looks extremely iffy.
The Motley Fool May 7, 2007 Anders Bylund	Foolish Forecast: Great Wolf's Gift of Gab The indoor water park operator is set to report quarterly earnings. Investors, here is what you can expect to see.
The Motley Fool May 7, 2007 Rick Aristotle Munarriz	The Future's All About.com Circulation rates, staffs, and page sizes keep getting smaller. However, New York Times has aggressively grown its online turf to compensate; even if it's cutting back elsewhere, the company's investment makes sense here. Investors, take note.
The Motley Fool May 7, 2007 Brian Lawler	ViroPharma Victorious A strong first quarter helps the pharmaceutical storm into 2007. Investors, take note.
The Motley Fool May 7, 2007 Toby Shute	Total's Results Totally Expected The oil company's strength lies upstream, so investors needn't worry.
The Motley Fool May 7, 2007 Rich Smith	Foolish Forecast: CompuCredit Sets the Stage The specialty finance company will report first quarter 2007 financial results tomorrow. Investors, here is what you can expect to see.
The Motley Fool May 7, 2007 Billy Fisher	Geo's Growth Unshackled The prison manager's growth can't be confined. Should investors keep their dollars locked up in Geo? If nothing else, it certainly beats being a customer.
The Motley Fool May 7, 2007 Steven Mallas	Not Swayed by Midway Midway Games continues to try to claw its way out of a barrel of red ink. The company still reported an operating and a net loss for the first quarter, but the negative numbers were smaller than what was reported last year.
The Motley Fool May 7, 2007 Ryan Fuhrmann	The Dust Settles at OfficeMax Does recent share price weakness warrant investment consideration in OfficeMax?
The Motley Fool May 7, 2007 Brian Lawler	Sanofi Rolls the Lawsuit Dice Investors, don't be fooled by rosy results; litigation risk still looms for the French drugmaker.
<Older 23031-23040 Newer> Return to current articles.